VERO Biotech is focused on the design, development, and commercialization of next-generation products to meet the needs of patients with a variety of pulmonary and cardiac diseases.
Location: United States, Georgia, Atlanta
Total raised: $145M
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 07.02.2024 | - | $65M | - |
| 11.01.2023 | - | $30M | - |
| 21.01.2021 | - | $50M | Runway Gro... |
Mentions in press and media 6
| Date | Title | Description |
| 07.02.2024 | Exclusive: Vero Biotech secures $65M credit facility for nitric oxide delivery system | Medical device company Vero Biotech received $65 million from Horizon Technology Finance and Monroe Capital, Vero Biotech board director Todd Brady tells Axios exclusively. Why it matters: The company's portable, tankless nitric oxide deliv... |
| 11.01.2023 | Vero Biotech Raises $30M in Financing | Vero Biotech, an Atlanta, GA-based commercial-stage healthcare business, raised $30M in funding. The round was led by Petrichor. Patrick Lally, Partner of Petrichor, has joined the VERO Biotech Board of Directors. The company intends to use... |
| 20.01.2021 | Vero Biotech Secures $50M in Funding | Vero Biotech LLC, an Atlanta, Georgia-based biotechnology company, closed a senior secured term loan of $50m. Runway Growth Capital provided the financing. Led by Brent V. Furse, CEO and President, Vero Biotech (formerly known as GeNO LLC) ... |
| 12.01.2021 | Runway Growth Capital Announces a Senior Secured Term Loan of $50 Million to VERO Biotech | |
| 12.01.2021 | Runway Growth Capital Announces a Senior Secured Term Loan of $50 Million to VERO Biotech | WOODSIDE, Calif., Jan. 12, 2021 – Runway Growth Capital LLC (“Runway”), a leading provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, today announced the close of a senior secu... |
| - | Vero Biotech | “Home - VERO Biotech” |